At Field Trip, our mission is to heal the sick, and better the well, through therapeutic psychedelics. We are a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics value chain — from basic research on botanical psychedelics to operation of world class clinics focused on psychedelics-assisted therapies.
Field Trip takes a personalized approach to mental wellness. We blend legal psychedelic-enhanced therapy, mindfulness, and self-care with a series of sessions with trained psychotherapists. All in a comfortable, spa-like environment that promotes healing.
Ketamine-enhanced psychotherapy is conducted at lower doses of ketamine than what has been used safely in anaesthesia for decades. Esketamine, a ketamine-derived drug, was the first FDA-approved drug to treat depression in 35 years. Our therapy uses lower doses of ketamine medication in a safe setting alongside psychotherapy. These lower doses can promote better mental health by disrupting thought patterns or loops that may be preventing progress.
Joseph del Moral, Founder, CEO
Board Member, Felix Health Inc. Founder of Grassfed Ventures, a VC and advisory firm. Co-founder and former CEO of Canadian Cannabis Clinics and CanvasRx. Former Board Member, Aurora Cannabis Inc
Ronan Levy, Founder, Executive Chairman
Board Member, Trait Biosciences Inc. Founder of Grassfed Ventures. Co-founder and former CCO of Canadian Cannabis Clinics and CanvasRx. Former SVP, Business & Corporate Affairs of Aurora Cannabis
Hannan Fleiman, Founder, President
Co-founder and COO of Canadian Cannabis Clinics and CanvasRx. Founder of Grassfed Ventures. Former President of Trait Biosciences Inc. MBA from McMaster University and a BSc Medical Toxicology from the University of Guelph.
Mujeeb Jafferi, Founder, Chief Operating Officer
Former President of Just Energy Solar; VP , Sales Strategy at Just Energy; Business Development at SunEdison. Bachelor’s from York University and a Global Professional. Master of Laws from Faculty of Law at the University of Toronto.
Dr. Ryan Yermus, Founder, Chief Clinical Officer
Founded the first legal medical cannabis clinic in Canada. Clinical expertise in the treatment of addictions. MD degree from University of Ottawa and residency completed at University of Toronto
Dr. Nathan Bryson, Ph.D, Chief Science Officer
Pharma executive with 25+ years in drug development. Chief Scientific Officer at Cynapsus Therapeutics and Acerus Pharmaceuticals. PhD in Chemistry from MIT; NATO post-doctoral fellow at Universite Louis Pasteur in Strasbourg, France.
Donna Wong, Chief Financial Officer
Managing Director, On Point Advisors. Principal, The CFO Centre Canada, former VP, Finance, ViXS Systems Inc.
Amardeep Manhas, Chief Technical Officer
Former VP, Operations, Crius Energy, LLC. Former VP, Operations, Lightwing/SunEdison, Former Director of Operations, Momentis Network.
Paula AmyHewitt, Vice President & General Counsel
Board Member, Caldwell Investment Management. Previously SVP, Chief Compliance Officer, Chief Privacy Officer and General Counsel at Raymond James Ltd.